Amit Verma is a Cardiology physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12201 Merit Dr Ste 550
Dallas, TX 752513131
Telephone
972-331-9700Registry record last updated 11 Sept 2018.
Clinical trials
- Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia
Sponsor: Albert Einstein College of Medicine
- Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Sponsor: Albert Einstein College of Medicine
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Stryker CorporationProgram year20252 payments
- UCB, Inc.Program year20241 payment
- Sumitomo Pharma America, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2016–2020 per NIH RePORTER. The latest:
- Therapeutic targeting of glutamine metabolism in MDS
University of Tx Md Anderson Can Ctr
FY2020$481,538R01CA206210 - Therapeutic targeting of glutamine metabolism in MDS
University of Tx Md Anderson Can Ctr
FY2019$467,092R01CA206210 - Therapeutic targeting of glutamine metabolism in MDS
University of Tx Md Anderson Can Ctr
FY2018$496,810R01CA206210
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”